In this regard, a previous study demonstrated that bevacizumab resistance increased with the expression of BCAT1 in IDH1-wildtype rat GBM, which was assessed by dynamic contrast susceptibility (DSC) perfusion MRI. Here, BCAT1 is linked to glioblastoma.